Chargement en cours...
Pharmacotherapy Effects on Smoking Cessation Vary with Nicotine Metabolism Gene (CYP2A6)
BACKGROUND AND AIMS: Evidence suggests that both the nicotinic receptor α5 subunit (CHRNA5) and Cytochrome P450 2A6 (CYP2A6) genotypes influence smoking cessation success and response to pharmacotherapy. We examine the effect of CYP2A6 genotype on smoking cessation success and response to cessation...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946972/ https://ncbi.nlm.nih.gov/pubmed/24033696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.12353 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|